REGIMI DI CHEMIOTERAPIA PER IL K PANCREAS NON OPERABILE: UNA MAGNIFICA NETWORK META-ANALISI DAL GRUPPO DELLA CATTOLICA DI ROMA. VINCONO NALIRIFOX E FOLFIRINOX. DA “THE LANCET ONCOLOGY” “
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis Luca Mastrantoni et al. Summary Background In advanced pancreatic ductal adenocarcinoma (PDAC), first-line chemotherapy is the standard of care. Due to the absence of head-to-head comparisons in clinical trials, we performed this systematic review and network…

